Levi Strauss Director Receives Routine Stock Award
LEVI STRAUSS & CO
Subscribe to track LEVI
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Levi Strauss Director Receives Routine Stock Award
Company: LEVI STRAUSS & CO (LEVI) Form: 4 | Filed: 2025-11-06 Significance: Low
Insider: McCormick Christopher J Title: Director | Relationship: Director
Transaction: • Type: Grant (Dividend Equivalents) • Shares: 263 (total) • Price: $0.00 • Value: $0 • Owned After: 127,830 (Class A & B)
Key Insight: A director received minor dividend equivalent rights, a routine form of non-cash compensation with no market-moving significance.
Market Context: The total shares awarded represent less than 0.001% of total shares outstanding for the $7.88B apparel company.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: LEVI STRAUSS & CO (LEVI)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a minor, zero-cost stock award in the form of dividend equivalent rights as part of a standard compensation plan.
- Market Impact: Neutral. The transaction is immaterial and represents a routine corporate action.
Company Information
| Field | Value |
|---|---|
| Company | LEVI STRAUSS & CO |
| Ticker Symbol | LEVI |
| CIK | 0000094845 |
| Market Capitalization | $7.88 billion |
Insider Information
| Field | Value |
|---|---|
| Name | McCormick Christopher J |
| CIK | 0001745717 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
This filing reports two related acquisitions of Dividend Equivalent Rights (DERs).
| Field | Transaction 1 | Transaction 2 |
|---|---|---|
| Form Type | 4 | 4 |
| Transaction Date | 2025-11-04 | 2025-11-04 |
| Transaction Code | A (Award) | A (Award) |
| Security Type | Class A Common Stock | Class B Common Stock |
| Shares Involved | 221 | 42 |
| Price Per Share | $0.00 | $0.00 |
| Total Value | $0 | $0 |
| Ownership Type | Direct | Direct |
| Shares Owned After | 70,324 | 57,506 |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Total Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Total Shares Transacted | 263 |
| % of Shares Outstanding | 0.00025% |
| Post-Transaction Ownership | 127,830 shares (0.119% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value is $0, making it financially insignificant relative to the company's $7.88 billion market capitalization.
- Ownership Concentration: The award slightly increases the director's total holdings to 0.119% of all outstanding shares, which is not a concentrated position.
- Dilution Impact: The issuance of 263 new shares represents a negligible dilution of 0.00025% to existing shareholders.
- Transaction Significance: The transaction is a routine grant of dividend equivalents, a common form of director compensation, and carries no significant market signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-cash, pre-planned compensation event. It does not reflect a discretionary investment decision by the insider and is too small to have any market impact.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is an award, not an open-market trade.
- Sentiment Indicator: Neutral. The filing is informational and does not imply any bullish or bearish sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The shares were acquired as Dividend Equivalent Rights (DERs), which are contingent rights to receive stock tied to underlying awards. This is a standard part of director compensation packages and not an open-market purchase.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
